In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer’s Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer’s Disease
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-09-09
DOI
10.1038/srep33172
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments
- (2016) Tangui Maurice BEHAVIOURAL BRAIN RESEARCH
- Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update
- (2015) Melissa A. Bradley-Whitman et al. ARCHIVES OF TOXICOLOGY
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Polypharmacology: the rise of multitarget drugs over combination therapies
- (2014) Michela Rosini Future Medicinal Chemistry
- Multi-target Design Strategies in the Context of Alzheimer’s Disease: Acetylcholinesterase Inhibition and NMDA Receptor Antagonism as the Driving Forces
- (2014) Michela Rosini et al. NEUROCHEMICAL RESEARCH
- 2013 Alzheimer's disease facts and figures
- (2013) Alzheimers & Dementia
- Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?
- (2013) Michela Rosini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Blockade of Tau Hyperphosphorylation and Aβ1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer’s Disease
- (2013) Valentine Lahmy et al. NEUROPSYCHOPHARMACOLOGY
- Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
- (2013) Chris G. Parsons et al. NEUROTOXICITY RESEARCH
- Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats
- (2013) Charleine Zussy et al. PLoS One
- Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity
- (2013) João P. Lopes et al. Brain and Behavior
- The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1–42 seeding and short-term memory deficits in the Aβ25–35 mouse model of Alzheimer's disease
- (2012) Johann Meunier et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer’s Disease
- (2012) Elena Simoni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synergistic Effects of Galantamine and Memantine in Attenuating Scopolamine-Induced Amnesia in Mice
- (2012) Perrine Busquet et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Time-Course and Regional Analyses of the Physiopathological Changes Induced after Cerebral Injection of an Amyloid β Fragment in Rats
- (2011) Charleine Zussy et al. AMERICAN JOURNAL OF PATHOLOGY
- Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
- (2011) Rommy von Bernhardi et al. ANTIOXIDANTS & REDOX SIGNALING
- Alzheimer's disease
- (2011) Clive Ballard et al. LANCET
- Memantine Preferentially Blocks Extrasynaptic over Synaptic NMDA Receptor Currents in Hippocampal Autapses
- (2010) P. Xia et al. JOURNAL OF NEUROSCIENCE
- Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative
- (2010) Vanessa Villard et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35
- (2009) Yury G. Kaminsky et al. EXPERIMENTAL NEUROLOGY
- Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
- (2008) Andrea Cavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antiamnesic and Neuroprotective Effects of the Aminotetrahydrofuran Derivative ANAVEX1-41 Against Amyloid β25–35-Induced Toxicity in Mice
- (2008) Vanessa Villard et al. NEUROPSYCHOPHARMACOLOGY
- The anti-amnesic and neuroprotective effects of donepezil against amyloid β25-35 peptide-induced toxicity in mice involve an interaction with the σ1 receptor
- (2006) J Meunier et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search